mRNA Cancer Vaccines Show Promise But Are Dogged by Misinformation
mRNA-based cancer vaccine research is at a pivotal stage, with early findings suggesting these vaccines can generate long-lived T-cell responses and might help overcome resistance to immune checkpoint inhibitors — and, one day, could even open the door to universal cancer vaccines.
Explore further at Cancer Therapy Advisor